COMPANY OVERVIEW

Imago BioSciences is translating epigenetics insights into high impact therapeutic programs aimed at transforming treatments allowing patients to live longer, disease-free lives.

---

LOCATION

San Francisco, CA, USA

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://www.imagobio.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jul 30, 2021

Imago BioSciences Receives Orphan Designation From European Medicines Agency for Bomedemstat for the Treatment of Essential Thrombocythemia

Jul 26, 2021

Imago BioSciences, Inc. Announces Exercise of Underwriters’ Option to Purchase Additional Shares

Jul 20, 2021

Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering

Jul 15, 2021

Imago BioSciences, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock

Jul 12, 2021

Imago BioSciences, Inc. Announces Proposed Initial Public Offering of Common Stock

For More Press Releases

---